Oxford Lane Capital Corp. 6.25% Series 2027 Term Preferred Shares (OXLCP)
FairStock Score: 48/100 — MIXED
Key Financials
| Current Price | $25.01 |
| Market Cap | — |
| P/E Ratio | 28.75 |
| ROE | -39.17% |
| Dividend Yield | 6.25% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Viewed as a preferred security, not common equity, OXLCP is a fixed-income instrument: a 6.25% coupon on $25 par, due 2027, priced at $25.01 on 2026-10-13. That is essentially par, so the buyer is collecting the coupon, not buying a bargain. Graham would flinch at the valuation signals: FairStock's Graham Number is $14.38, leaving a margin of safety of -73.92%; at the 2026-10-13 close, FairStock's P/B is 2.37 and P/E is 28.75. FairStock's return metrics are not reassuring: ROE is -39.17%, ROCE is 8.98%, Piotroski F-Score is 0/9, and FairStock Score is 48/100. No Lynch category can be assigned because there are only 0 years of filed results, needing 3. Beta of 0.64 offers some offset, and the 52-week range of $24.28-$25.09 shows price stability. But a preferred share's safety comes from asset coverage and cash flow, not from a low beta. Oxford Lane invests in securitization vehicles holding below-investment-grade or unrated senior secured loans. That is a credit-sensitive, leveraged business; D/E is 0.75. With a 6.25% coupon on $25 par, preferred dividend coverage deserves close attention. There is no revenue or profit growth data, and the Lynch rule says none. My conclusion: this is a coupon-clipping credit instrument trading at full price. If credit markets remain calm through 2027, the 6.25% yield may be earned. If defaults rise or asset values fall, the preferred's dividends and par value are exposed. I see no margin of safety at $25.01.
In plain English: Oxford Lane Capital Corp. 6.25% Series 2027 Term Preferred Shares are an income investment tied to a fund that invests in risky loans through packaged debt pools. The fund's reported numbers look weak, with deeply negative profits on equity and a very low financial-health score. At about $25, the shares trade near their 52-week high and look expensive compared with the value suggested by the fund's earnings and book value.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer